Results 161 to 170 of about 198,685 (310)

47 Early molecular response kinetics to induction chemotherapy and anti-PD1 immunotherapy in HPV-positive head and neck squamous cell carcinoma (HNSCC) patients [PDF]

open access: hybrid
Min Tang   +6 more
openalex   +1 more source

Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis

open access: green, 2021
Sarwat Naz   +10 more
openalex   +2 more sources

Limited Sensitivity of Ultrasound‐Guided Fine‐Needle Aspiration Cytology for Occult Nodal Metastases in Early‐Stage Oral Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Ultrasound‐guided fine‐needle aspiration cytology (US‐FNAC) is commonly used in the diagnostic work‐up of head and neck cancer, but its ability to detect occult lymph node metastases in early‐stage oral squamous cell carcinoma (OSCC) with a clinically negative neck remains unclear.
Dominique N. V. Donders   +7 more
wiley   +1 more source

An in vitro study showing the three-dimensional microenvironment influence over the behavior of head and neck squamous cell carcinoma

open access: bronze, 2011
Fernanda Salgueiredo-Giudice   +4 more
openalex   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin   +9 more
wiley   +1 more source

A Pan‐Cancer Microenvironment Atlas Constructed by DECEPTICONx

open access: yesiMetaMed, EarlyView.
DECEPTICONx builds the most comprehensive pan‐cancer TME atlas to date from > 11,000 TCGA samples using 535,665 single cells, revealing 102 immune/stromal subtypes with robust novel associations to patient outcomes, immunotherapy response, and intercellular coordination in the TME.
Yida Gu   +14 more
wiley   +1 more source

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma [PDF]

open access: bronze, 2007
Christine Elser   +12 more
openalex   +1 more source

Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort

open access: yesInterdisciplinary Medicine, EarlyView.
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li   +10 more
wiley   +1 more source

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

open access: yesAnnals of Oncology, 2017
E. Saâda-Bouzid   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy